The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.
Cancer Cell
; 41(4): 711-725.e6, 2023 04 10.
Article
in En
| MEDLINE
| ID: mdl-36898378
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Cell
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article